D-Glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo

British Journal of Cancer

Volumn 105, Issue 1, 2011, Pages 74-82

  Grigorieva, E V ^a,b   Prudnikova, T Y ^a   Domanitskaya, N V ^a   Mostovich, L A ^a   Pavlova, T V ^b   Kashuba, V I ^b,c   Zabarovsky, E R ^b,d  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

angiogenesis; D Glucuronyl C5 epimerase; heparan sulphate proteoglycan; metastasis; small cell lung cancer; tumour suppressor gene

Indexed keywords

ANTINEOPLASTIC AGENT; DEXTRO GLUCURONYL C5 EPIMERASE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GELATINASE A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTEMATIC REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, WESTERN; CARBOHYDRATE EPIMERASES; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; MICE, SCID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED;

EID: 79959727731     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.170     Document Type: Article

References (50)

1. Aikawa T, Whipple CA, Lopez ME, Gunn J, Young A, Lander AD, Korc M (2008) Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. J Clin Invest 118: 89-99
2. Alexopoulou AN, Multhaupt HA, Couchman JR (2007) Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39: 505-528 (Pubitemid 46099032)
3. Appelmann I, Liersch R, Kessler T, Mesters RM, Berdel WE (2010) Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy. Recent Results Cancer Res 180: 51-81
4. Azam F, Mehta S, Harris AL (2010) Mechanisms of resistance to antiangiogenesis therapy. Eur J Cancer 46(8): 1323-1332
5. Blackhall FH, Merry CL, Davies EJ, Jayson GC (2001) Heparan sulfate proteoglycans and cancer. Br J Cancer 85: 1094-1098 (Pubitemid 33052304)
6. Brueckl WM, Schoeberl A, Wirtz RM, Murray S, Hahn EG, Wiest GH (2008) Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC). J Thorac Oncol 3: 314-316 (Pubitemid 351654333)
7. Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, Gherardi E, Gallagher JT, Pavão MS, Lyon M (2008) Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J Biol Chem 283: 5235-5248
8. Crawford BE, Olson SK, Esko JD, Pinhal MA (2001) Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J Biol Chem 276: 21538-21543
9. Eshchenko TY, Rykova VI, Chernakov AE, Sidorov SV, Grigorieva EV (2007) Expression of different proteoglycans in human breast tumors. Biochemistry (Mosc) 72: 1016-1020 (Pubitemid 47518859)
10. Filmus J, Capurro M, Rast J (2008) Glipicans. Genome Biol 9: 224
11. Grigorieva E, Eshchenko T, Rykova VI, Chernakov A, Zabarovsky E, Sidorov SV (2008) Decreased expression of human D-glucuronyl C5-epimerase in breast cancer. Int J Cancer 122: 1172-1176 (Pubitemid 351214017)
12. Hann CL, Rudin CM (2007) Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer. Trends Mol Med 13: 150-157 (Pubitemid 46498831)
13. Harbeck N, Kates RE, Gauger K, Willems A, Kiechle M, Magdolen V, Schmitt M (2004) Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer. Thromb Haemost 91: 450-456 (Pubitemid 38396866)
14. Helfman DM, Kim EJ, Lukanidin E, Grigorian M (2005) The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92: 1955-1958 (Pubitemid 40897415)
15. Iozzo RV (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 6: 646-656 (Pubitemid 41081268)
16. Iozzo RV, Zoeller JJ, Nyström A (2009) Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol Cells 27: 503-513
17. Jia J, Maccarana M, Zhang X, Bespalov M, Lindahl U, Li JP (2009) Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem 284: 15942-15950
18. Katoh Y, Katoh M (2009) FGFR2-related pathogenesis and FGFR2-targeted therapeutics. Int J Mol Med 23: 307-311
19. Kim BT, Kitagawa H, Tamura J, Saito T, Kusche-Gullberg M, Lindahl U, Sugahara K (2001) Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proc Natl Acad Sci USA 98(13): 7176-7181 (Pubitemid 32567922)
20. Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, Lange J, D'Armiento JM, Rothman PB, Powell CA (2003) The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol 29: 694-701 (Pubitemid 38054366)
21. Lander AD, Selleck SB (2000) The elusive functions of proteoglycans: in vivo veritas. J Cell Biol 148: 227-232 (Pubitemid 30078233)
22. Li J, Protopopov AI, Gizatullin RZ, Kiss C, Kashuba VI, Winberg G, Klein G, Zabarovsky ER (1999) Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene. FEBS Lett 451(3): 289-294 (Pubitemid 29243794)
23. Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U (2001) Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 276: 20069-20077
24. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, Zhang X, Lindahl U (2003) Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278: 28363-28366 (Pubitemid 36935735)
25. Li JP, Hagner-McWhirter A, Kjellén L, Palgi J, Jalkanen M, Lindahl U (1997) Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem 272: 28158-28163 (Pubitemid 27473627)
26. Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem 273(41): 26265-26268 (Pubitemid 28471622)
27. Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R (2009) Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. Int J Immunopathol Pharmacol 22: 627-638
28. Merrick DT, Haney J, Petrunich S, Sugita M, Miller YE, Keith RL, Kennedy TC, Franklin WA (2005) Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. Lung Cancer 48: 31-45 (Pubitemid 40380998)
29. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massagué J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524 (Pubitemid 41112921)
30. Mostovich LA, Prudnikova TY, Domanitskaya NV, Verzhbitskaya NE, Kharchenko OV, Nepomnyaschikh GI, Aidagulova SV, Rykova VI, Grigoryeva EV (2010) in vivo. Siber J Oncol 2: 24-29
31. Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G (1997) Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer 74: 335-345 (Pubitemid 27321806)
32. Nadanaka S, Kitagawa H (2008) Heparan sulphate biosynthesis and disease. J Biochem 144: 7-14 (Pubitemid 351957475)
33. Nagaraj NS, Datta PK (2010) Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs 19: 77-91
34. Offersen BV, Pfeiffer P, Andreasen P, Overgaard J (2007) Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Lung Cancer 56: 43-50 (Pubitemid 46356642)
35. Okada M, Nadanaka S, Shoji N, Tamura JI, Kitagawa H (2010) Biosynthesis of heparan sulfate in EXT1-deficient cells. Biochem J 428: 463-471
36. Ori A, Wilkinson MC, Fernig DG (2008) The heparanome and regulation of cell function: structures, functions and challenges. Front Biosci 13: 4309-4338 (Pubitemid 351599686)
37. Overall CM, López-Otín C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2: 657-672 (Pubitemid 37328917)
38. Pastorino U (2010) Lung cancer screening. Br J Cancer 102: 1681-1686
39. Protopopov AI, Li J, Winberg G, Gizatullin RZ, Kashuba VI, Klein G, Zabarovsky ER (2002) Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. J Gene Med 4: 397-406 (Pubitemid 40277177)
40. Prudnikova TY, Mostovich LA, Domanitskaya NV, Pavlova TV, Kashuba VI, Zabarovsky ER, Grigorieva EV (2010) Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells. Cancer Cell Int 10: 27
41. Reijmers RM, Groen RW, Rozemuller H, Kuil A, de Haan-Kramer A, Csikós T, Martens AC, Spaargaren M, Pals ST (2010) Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma. Blood 115: 601-604
42. Ropero S, Setien F, Espada J, Fraga MF, Herranz M, Asp J, Benassi MS, Franchi A, Patiño A, Ward LS, Bovee J, Cigudosa JC, Wim W, Esteller M (2004) Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Hum Mol Genet 13: 2753-2765 (Pubitemid 39562540)
43. Rosti G, Bevilacqua G, Bidoli P, Portalone L, Santo A, Genestreti G (2006) Small cell lung cancer. Ann Oncology 17(Suppl 2): ii5-ii10
44. Schulz WA (2005) Molecular Biology of Human Cancers, p 208. AA Dordrecht: The Netherlands
45. Toh Y, Nicolson GL (2009) The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26: 215-227
46. Whitelock JM, Melrose J, Iozzo RV (2008) Diverse cell signaling events modulated by perlecan. Biochemistry 47: 11174-11183
47. Zhang C, Fu L, Fu J, Hu L, Yang H, Rong TH, Li Y, Liu H, Fu SB, Zeng YX, Guan XY (2009) Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res 15: 4017-4027
48. Zoeller JJ, Whitelock JM, Iozzo RV (2009) Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biol 28: 284-291
49. Zong F, Fthenou E, Castro J, acute;terfia B, Kovalszky I, lák L, Tzanakakis G, Dobra K (2010) Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains. Cell Prolif 43: 29-40
50. Zong F, Fthenou E, Wolmer N, Hollo'si P, Kovalszky I, Szilák L, Mogler C, Nilsonne G, Tzanakakis G, Dobra K (2009) Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. PLoS One 4(10): e7346